LLS's continued advancements over the years, are responsible for the blood cancer survival rate doubling and tripling; in some cases, the survival rate has even quadrupled. Many LLS supported therapies not only help blood cancer patients but are now used to treat patients with rare forms of stomach and skin cancers. They're even being tested in clinical trials for patients with a range of cancers including lung, brain, breast, pancreatic and prostate cancers. LLS funded drugs like Gleevec, Sprycel, Arinza, Tasigna and Zolinza are now being tested for patients with other non-cancerous diseases like Diabetes, Rheumatoid Arthritis and Multiple Sclerosis. All donations are greatly appreciated and are tax deductible. They'll not only support LLS research but patient services, advocacy, public and professional education, and community services as well. Please visit my Web site often and bring friends who would also like to donate! On behalf of blood cancer patients everywhere I thank you for your support!

Gloriana Laskowski-Cohen